Cervical cancer is both treatable and preventable, and the WHO has called for countries to come together to to eliminate the disease in the next century.
However the disease still kills over 300,000 people each year, and levels of screening, treatment and vaccination need to be stepped up in order to achieve this goal.
These challenges are particularly stark in low- and middle-income countries, where a lack of funding, staffing and infrastructure are obstacles. Vaccine hesitancy, especially in light of the COVID-19 pandemic, is also a key problem.
In this Podcast Extra, two experts share their thoughts on how best to overcome these obstacles, and make elimination of cervical cancer a reality.
Comment: Cervical cancer kills 300,000 people a year — here’s how to speed up its elimination
Subscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.
Hosted on Acast. See acast.com/privacy for more information.
Audio long-read: The chase for fusion energy
Coronapod: everything we know about the new COVID variant
Researcher careers under the microscope: salary satisfaction and COVID impacts
Sea squirts teach new lessons in evolution
Coronapod: new hope from COVID antiviral drugs
The past and future of the Earth's climate
Audio long-read: How dangerous is Africa’s explosive Lake Kivu?
Podcast special: onboard the climate train to COP26
China’s COVID vaccines have been crucial — now immunity is waning
Genomics unwraps mystery of the Tarim mummies
Coronapod: can scientists harness COVID super-immunity?
Viking presence in the Americas pinpointed by ancient solar storm
Coronapod: the COVID scientists facing violent threats
How electric acupuncture zaps inflammation in mice
Coronapod: new data affirms the benefits of air filters and masks
The AI that accurately predicts the chances of rain
Starting up in science: behind the scenes
Starting up in science: Episode 4
Starting up in science: Episode 3
Starting up in science: Episode 2
Create your
podcast in
minutes
It is Free